Bottom line
Is RSJN a good fund? The bottom line
RSJN is a managed buffer / defined outcome ETF from First Trust.
Annual fees run 0.85% — about $85 a year on every $10,000 invested, more expensive than 81% of buffer / defined outcome funds we track.
It returned +7.7% over one year (as of Dec 31, 2025, per its prospectus).
With $18.3 million in net assets and 9 holdings, its largest position is Cboe Global Markets, Inc. (61.4%) and the top 10 make up 100.1% of the portfolio.
What to watch
- Expensive for its category (0.85%)
- Concentrated: top 10 holdings are 100.1% of assets
- Small fund ($18.3 million) — small funds are likelier to close
Updated Nov 19, 2026
What RSJN invests in
The investment objective of the FT Vest U.S. Equity Equal Weight Buffer ETF June (the Fund ) is to seek to provide investors with returns (before fees and expenses) that match the price return of the Invesco S&P 500 Equal Weight ETF (the Underlying ETF ), up to a predetermined upside cap of 15.28% while providing a buffer (before fees and expenses) against the first 10% of Underlying ETF losses, over the period from June 22, 2026 through June 17, 2027.
"Under normal market conditions, the Fund will invest at least 80% of its net assets (plus any investment borrowings) in investments that provide exposure to equity securities issued by U.S. companies. Under normal market conditions, the Fund will invest substantially all of its assets in FLexible EXchange Options ( FLEX Options ) that reference the price performance of the Invesco S&P 500 Equal Weight ETF (the Underlying ETF ). FLEX Options are customized equity or index option contracts that trade on an exchange, but provide investors with the ability to customize key contract terms like exercise prices, styles and expiration dates. The Underlying ETF is an exchange-traded fund that employs a full replication methodology in seeking to track the S&P 500 Equal Weight Index, meaning that the Underlying ETF generally invests in all of the securities comprising the S&P 500 Equal Weight…
From the fund's prospectus (filed Sep 28, 2026).
RSJN performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RSJN | +7.7% | — | — |
| Buffer / Defined Outcome median | +10.6% | +2.2% | +2.9% |
Source: Fund prospectus, as of Dec 31, 2025
What RSJN costs
On a $10,000 investment, RSJN's 0.85% expense ratio costs about $85 a year. The median buffer / defined outcome fund charges 0.74%.
RSJN top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Cboe Global Markets, Inc. | 61.44% |
| 2 | Cboe Global Markets, Inc. | 30.50% |
| 3 | Cboe Global Markets, Inc. | 10.17% |
| 4 | Dreyfus Government Cash Management Funds | 0.33% |
| 5 | Cboe Global Markets, Inc. | 0.03% |
| 6 | Cboe Global Markets, Inc. | 0.00% |
| 7 | Cboe Global Markets, Inc. | 0.00% |
| 8 | Cboe Global Markets, Inc. | -0.01% |
| 9 | Cboe Global Markets, Inc. | -2.40% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 100.1% of the fund. See all top 25 holdings and asset mix →